Literature DB >> 21633856

The course of early-onset multiple sclerosis in Iraqi children.

Hasan A Al-Hamadani1, Atheer S Abdalla, Atheer J Al-Saffar.   

Abstract

BACKGROUND: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system that is increasingly recognized worldwide in children and adolescents. The current study aimed at identifying the clinical characteristics of MS with onset under 18 years of age.
METHODS: This cross-sectional study was conducted in the Multiple Sclerosis Center archive system in Baghdad Teaching Hospital during the period from March 1 to May 15, 2008. The records of 1125 MS patients from 2000 to 2008 were reviewed. Among them 77 patients had the onset of MS under 18 years of age.
RESULTS: Two thirds of the patients were female (a female/male ratio of 1.6:1). The mean age of the patients at the onset of the disease was 14.95 ± 3.21 years, and the mean time between the first and second attacks was 3.06 ± 4.09 years. Seventy patients (90.9%) had an initial course of relapse remitting MS. Among them 9 (12.9%) progressed to secondary progressive MS after a mean duration of 9.87 ± 4.14 years. The remaining 7 patients had primary progressive MS associated with optic neuritis and brain stem lesion. Fifty-nine (76.6%) patients had monofocal signs and 18 (23.4%) had polyfocal signs. The mean extended disability status scale score was 4.15 ± 2.17 and the mean progression index was 1.44 ± 2.31. There was a strong inversed correlation between the progression index and interval between the first and second attacks (P=0.0001).
CONCLUSIONS: The results of the present study show that the course of MS in Iraqi children and adolescents is more aggressive than in children from other countries. This finding needs to be evaluated by further studies.

Entities:  

Mesh:

Year:  2011        PMID: 21633856     DOI: 10.1007/s12519-011-0297-1

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  22 in total

1.  Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children.

Authors:  R C Dale; C de Sousa; W K Chong; T C Cox; B Harding; B G Neville
Journal:  Brain       Date:  2000-12       Impact factor: 13.501

2.  The natural history of early onset multiple sclerosis: comparison of data from Moscow and Vancouver.

Authors:  Eugin Gusev; Alexei Boiko; Olga Bikova; Olga Maslova; Maria Guseva; Svetlana Boiko; Galina Vorobeichik; Donald Paty
Journal:  Clin Neurol Neurosurg       Date:  2002-07       Impact factor: 1.876

3.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

4.  Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?

Authors:  Adnan Al-Araji; Ayad I Mohammed
Journal:  J Neurol Sci       Date:  2005-07-15       Impact factor: 3.181

5.  Juvenile multiple sclerosis: clinical features and prognostic characteristics.

Authors:  O Pinhas-Hamiel; Y Barak; I Siev-Ner; A Achiron
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

6.  Optic neuritis in children: recurrence and subsequent development of multiple sclerosis.

Authors:  P Visudhiphan; S Chiemchanya; S Santadusit
Journal:  Pediatr Neurol       Date:  1995-11       Impact factor: 3.372

7.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

Review 8.  Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions.

Authors:  Brenda Banwell; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu
Journal:  Lancet Neurol       Date:  2007-10       Impact factor: 44.182

Review 9.  Multiple sclerosis in children.

Authors:  Natan Gadoth
Journal:  Brain Dev       Date:  2003-06       Impact factor: 1.961

10.  Natural history of multiple sclerosis with childhood onset.

Authors:  Christel Renoux; Sandra Vukusic; Yann Mikaeloff; Gilles Edan; Michel Clanet; Bénédicte Dubois; Marc Debouverie; Bruno Brochet; Christine Lebrun-Frenay; Jean Pelletier; Thibault Moreau; Catherine Lubetzki; Patrick Vermersch; Etienne Roullet; Laurent Magy; Marc Tardieu; Samy Suissa; Christian Confavreux
Journal:  N Engl J Med       Date:  2007-06-21       Impact factor: 91.245

View more
  1 in total

Review 1.  Multiple Sclerosis in Pediatrics: Current Concepts and Treatment Options.

Authors:  Jasna Jancic; Blazo Nikolic; Nikola Ivancevic; Vesna Djuric; Ivan Zaletel; Dejan Stevanovic; Sasa Peric; John N van den Anker; Janko Samardzic
Journal:  Neurol Ther       Date:  2016-09-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.